XML 30 R5.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Consolidated Statement of Changes in Equity - USD ($)
Series A
Preferred Stock
Series B
Preferred Stock
Common Stock
Share Premium
Additional Paid in Capital
Accumulated Other Comprehensive Loss
Accumulated Deficit
Total
Balance at Dec. 31, 2020 $ 12,722,511 $ 90   $ 181,191 $ 246,203 $ (10,464,219) $ 2,685,776
Balance (in Shares) at Dec. 31, 2020 10,076,873 9,000,000        
Retroactive application of recapitalization $ (12,722,511)   $ 2,348   (181,191)      
Retroactive application of recapitalization (in Shares) (10,076,873)   15,386,330 12,901,354        
Net loss   (14,472,494) (14,472,494)
Issuance of warrant     345,880
Issuance of warrant (in Shares)       345,880        
Issuance of common stock upon settlement of restricted stock units $ 436     (34) 767,908
Issuance of common stock upon settlement of restricted stock units (in Shares) 4,360,419 767,506        
Conversion of convertible notes into common stocks   $ 481   8,848,947
Conversion of convertible notes into common stocks (in Shares)     4,811,618 8,848,466        
Issuance of common stock   $ 1,051   29,710,000
Issuance of common stock (in Shares)     10,509,396 29,708,949        
Stock-based compensation       83,843
Stock-based compensation (in Shares)       83,843        
Exercise of stock-based awards $ 3     17,005
Exercise of stock-based awards (in Shares) 32,437 17,002        
Foreign currency translation adjustment   (7,467,497)   (7,467,497)
Balance at Dec. 31, 2021     $ 4,409     (7,221,294) (24,936,747) $ 20,519,368
Balance (in Shares) at Dec. 31, 2021     44,100,200 52,673,000       44,100,200
Net loss   (14,245,878) $ (14,245,878)
Stock-based compensation     1,657,709
Stock-based compensation (in Shares)       1,657,709        
Exercise of stock-based awards $ 2     5,174
Exercise of stock-based awards (in Shares) 19,974 5,172        
Foreign currency translation adjustment   (336,705)   (336,705)
Balance at Dec. 31, 2022     $ 4,411     (7,557,999) (39,182,625) 7,599,668
Balance (in Shares) at Dec. 31, 2022     44,120,174 54,335,881        
Net loss   (33,814,719) (33,814,719)
Issuance of common stock upon settlement of restricted stock units     $ 846       (846)  
Issuance of common stock upon settlement of restricted stock units (in Shares)     8,461,504          
Repurchase of private/public warrants and reclassification of public warrants from equity to liability             7,391,994 (1,270,499)
Repurchase of private/public warrants and reclassification of public warrants from equity to liability (in Shares)       (8,662,493)        
Stock-based compensation     1,983,760
Stock-based compensation (in Shares)       1,983,760        
Exercise of stock-based awards $ 9     8,125
Exercise of stock-based awards (in Shares) 89,482 8,116        
Exercise of PFG warrant     $ 15          
Exercise of PFG warrant (in Shares)     146,671 (15)        
Issuance of common stock upon reverse recapitalization, net of fees     $ 422         (7,203,993)
Issuance of common stock upon reverse recapitalization, net of fees (in Shares)     4,218,263 (7,204,415)        
Balance at Dec. 31, 2023 $ 5,703     $ (7,557,999) $ (65,606,196) $ (32,697,658)
Balance (in Shares) at Dec. 31, 2023 57,036,094 40,460,834